Lead
The Department of Health and Human Services is preparing a proposal to change the recommended childhood vaccine schedule in the United States to include fewer shots, a person familiar with the plans told CNN on . The source said the draft would bring U.S. guidance closer to recommendations published for Denmark in 2025. The plan has not been finalized and an HHS announcement originally expected later this month was delayed until 2026. HHS declined to comment beyond a prior statement that a “children’s health announcement” had been postponed.
Key Takeaways
- HHS is reviewing a revised childhood immunization schedule that would recommend fewer doses and align more closely with Denmark’s 2025 schedule, according to an anonymous source.
- The proposed changes would remove or de-emphasize vaccines that Denmark does not recommend for children, including RSV, rotavirus, pneumococcal, hepatitis A, meningococcal and chickenpox vaccines.
- The revision is not final; a planned announcement was pushed into 2026 to avoid clashing with White House measures on drug pricing, the source said.
- President Donald Trump directed a review of the U.S. schedule weeks earlier via a presidential memorandum that asked officials to fast-track comparisons with other countries.
- Public health experts warn that differences in health systems, prenatal care access and national registries make simple adoption of another country’s schedule risky for the U.S.
- HHS Secretary Robert F. Kennedy Jr. publicly acknowledged the effort and said the agency is working on it.
Background
The review follows a presidential memorandum that ordered federal agencies to evaluate how U.S. childhood vaccine timing and content compare with other high-income countries. Officials cited a desire to review schedules “from other countries around the world” and consider closer alignment. The source told CNN the draft would narrow the U.S. schedule to resemble Denmark’s 2025 recommendations as summarized by the European public health agency.
Denmark’s approach to childhood vaccination is embedded within a health system that features high prenatal screening uptake, a national health registry and universal coverage for routine care. U.S. public health officials and clinicians point out that those structural differences influence disease risk, follow-up rates and vaccine program outcomes. Advocates of the U.S. schedule emphasize that vaccines such as rotavirus and pneumococcal disease prevention have demonstrable impacts on hospitalization and mortality in American children.
Main Event
The person who spoke to CNN said HHS had aimed to unveil the revised schedule late in the week but moved the public rollout into 2026 to avoid overlap with planned White House announcements on drug pricing, including Most Favored Nation pricing initiatives. HHS has, according to the agency’s prior statement, postponed a separate “children’s health announcement” until next year and declined additional comment to CNN when contacted.
Under the draft described to CNN, the new schedule would remove or delay recommendations for a number of vaccines that Denmark does not routinely give to children, including vaccines for RSV, rotavirus, pneumococcus, hepatitis A, meningococcal disease and varicella. The source said the intention is to reduce the number of well-child injections and bring U.S. guidance into closer alignment with the Danish list.
Several leading vaccine experts reacted sharply. Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, questioned the logic of emulating Denmark’s list if it means accepting more preventable illness. Dr. Peter Hotez, director of the Center for Vaccine Development at Texas Children’s Hospital, called the move surprising given the administration’s recent rhetoric and warned it could reduce availability of vaccines that prevent serious illnesses in U.S. children.
At a recent meeting of CDC vaccine advisers, Dr. Tracy Beth Hoeg, acting director at FDA’s Center for Drug Evaluation and Research, presented details about the Danish schedule and noted that Denmark’s deliberations are less politicized and benefit from multiparty debate and structured acceptance of uncertainty. Dr. Adam Langer, a CDC hepatitis B expert, highlighted practical differences — including Denmark’s near-universal prenatal hepatitis B screening and a national registry — and cautioned against treating Denmark as a direct peer.
Analysis & Implications
Shifting the U.S. schedule toward fewer routine childhood vaccines could change the balance of disease prevention, cost and resource allocation. In countries with universal prenatal screening, small-population registries and near-complete follow-up, fewer routine infant doses may be supported by system-level safeguards that the U.S. does not uniformly possess. Absent comparable infrastructure, reducing vaccine recommendations could raise the risk that vulnerable infants are left unprotected.
Proponents of fewer doses often cite lower exposure to adjuvants such as aluminum, fewer clinic visits and perceived reductions in medical intervention. However, broad scientific reviews have found aluminum-containing adjuvants safe at the doses used in vaccines, and reducing vaccines can increase disease burden if alternative prevention and follow-up mechanisms are not strengthened. Any proposal that removes specific vaccines would require careful modeling of expected hospitalizations, morbidity and deaths across U.S. subpopulations.
Politically, the review sits at the intersection of administration priorities on health care, public perceptions of vaccine safety and efforts to lower drug costs. The coming months could see intense scrutiny from state public health departments, pediatric societies and advocacy groups; changes to the federal recommended schedule would also prompt discussion about insurance coverage, school-entry requirements and federal advisory committee processes.
Comparison & Data
| Disease / Vaccine | U.S. Recommendation | Denmark (2025) |
|---|---|---|
| Respiratory syncytial virus (RSV) | Yes | No |
| Rotavirus | Yes | No |
| Pneumococcal | Yes | No |
| Hepatitis A | Yes | No |
| Meningococcal | Yes | No |
| Chickenpox (Varicella) | Yes | No |
The table reflects vaccines specifically mentioned by public sources comparing U.S. guidance with Denmark’s 2025 schedule. These are not exhaustive; national immunization programs differ in scope, target age groups and policy rationale. The practical impact of removing a recommendation depends on disease incidence, health-care access, follow-up systems and other non-vaccine interventions in place.
Reactions & Quotes
White House and HHS signals have amplified attention on the review. President Trump framed the current U.S. schedule as excessive in public posts and instructed federal agencies to reevaluate international approaches.
‘It is ridiculous!’
President Donald J. Trump (public post)
HHS leadership acknowledged the task publicly on social media while officials declined to provide details to reporters. The department has said it will postpone a related announcement until next year.
‘Thank you, Mr. President. We’re on it.’
HHS Secretary Robert F. Kennedy Jr. (social post)
Independent clinicians emphasized the need for epidemiological grounding rather than simple policy transfers from one national health system to another.
‘Why would we ever want to emulate that? They decided to allow more suffering and hospitalization to save money.’
Dr. Paul Offit, Vaccine Education Center, Children’s Hospital of Philadelphia
Unconfirmed
- The exact contents of the final HHS proposal remain unconfirmed; the source told CNN the draft could change before any official release.
- It is not confirmed that the U.S. schedule will be identical to Denmark’s 2025 recommendations; descriptions to date indicate close alignment but not final parity.
- How the proposed changes would affect hospitalization or mortality rates across diverse U.S. communities has not been publicly modeled or released.
Bottom Line
HHS is undertaking a review that could narrow the U.S. childhood vaccine schedule to more closely match Denmark’s 2025 guidance, but the proposal is preliminary and its public unveiling has been delayed until 2026. The move reflects a policy decision intertwined with political priorities, public concerns about dosing and debates over health-system differences between the United States and smaller, more centralized systems.
Any substantive change to federal vaccine recommendations would have wide-ranging implications for disease prevention, insurance coverage and state-level requirements. Policymakers should ensure that epidemiological evidence, surveillance capacity and equitable access to care guide final decisions; stakeholders will be watching for detailed modeling and the HHS advisory process when the proposal is formally released.
Sources
- CNN — U.S. news report based on anonymous source and official statements.
- European Centre for Disease Prevention and Control (ECDC) — European public health agency; summary materials on national immunization schedules.
- Centers for Disease Control and Prevention (CDC) — U.S. federal public health agency; advisory meetings and vaccine schedules.
- Children’s Hospital of Philadelphia (CHOP) — Hospital research and vaccine education center (expert commentary from Dr. Paul Offit).
- Texas Children’s Hospital — Hospital research center (expert commentary from Dr. Peter Hotez).